Literature DB >> 23493396

Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1).

Theresa N Ramos1, Daniel C Bullard, Meghan M Darley, Kristin McDonald, David F Crawford, Scott R Barnum.   

Abstract

Cerebral malaria (CM) is a severe clinical complication of Plasmodium falciparum malaria infection and is characterized by a high fatality rate and neurological damage. Sequestration of parasite-infected red blood cells in brain microvasculature utilizes host- and parasite-derived adhesion molecules and is an important factor in the development of CM. ICAM-1, an alternatively spliced adhesion molecule, is believed to be critical on endothelial cells for infected red blood cell sequestration in CM. Using ICAM-1 mutant mice, we found that the full-length ICAM-1 isoform is not required for development of murine experimental CM (ECM) and that ECM phenotype varies with the combination of ICAM-1 isoforms expressed. Furthermore, we observed development of ECM in transgenic mice expressing ICAM-1 only on leukocytes, indicating that endothelial cell expression of this adhesion molecule is not required for disease pathogenesis. We propose that ICAM-1-dependent cellular aggregation, independent of ICAM-1 expression on the cerebral microvasculature, contributes to ECM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23493396      PMCID: PMC3630868          DOI: 10.1074/jbc.C113.457028

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Role of ICAM-1 (CD54) in the development of murine cerebral malaria.

Authors:  N Favre; C Da Laperousaz; B Ryffel; N A Weiss; B A Imhof; W Rudin; R Lucas; P F Piguet
Journal:  Microbes Infect       Date:  1999-10       Impact factor: 2.700

2.  Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.

Authors:  G A Limb; L Webster; H Soomro; S Janikoun; J Shilling
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

3.  ICAM-1-dependent tuning of memory CD8 T-cell responses following acute infection.

Authors:  Maureen A Cox; Scott R Barnum; Daniel C Bullard; Allan J Zajac
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

4.  Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis.

Authors:  Xianzhen Hu; Scott R Barnum; Jillian E Wohler; Trenton R Schoeb; Daniel C Bullard
Journal:  Mol Immunol       Date:  2010-04-03       Impact factor: 4.407

5.  The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria.

Authors:  Theresa N Ramos; Meghan M Darley; Sebastian Weckbach; Philip F Stahel; Stephen Tomlinson; Scott R Barnum
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

6.  Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1.

Authors:  N K van Den Engel; E Heidenthal; A Vinke; H Kolb; S Martin
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

7.  Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria.

Authors:  J D Smith; A G Craig; N Kriek; D Hudson-Taylor; S Kyes; T Fagan; T Fagen; R Pinches; D I Baruch; C I Newbold; L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

8.  Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria.

Authors:  T N Ramos; D C Bullard; S R Barnum
Journal:  Parasite Immunol       Date:  2012-11       Impact factor: 2.280

9.  Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model.

Authors:  Joseph H Chewning; Kari J Dugger; Tandra R Chaudhuri; Kurt R Zinn; Casey T Weaver
Journal:  BMC Immunol       Date:  2009-08-03       Impact factor: 3.615

10.  Neuroimmunological blood brain barrier opening in experimental cerebral malaria.

Authors:  Adela Nacer; Alexandru Movila; Kerstin Baer; Sebastian A Mikolajczak; Stefan H I Kappe; Ute Frevert
Journal:  PLoS Pathog       Date:  2012-10-25       Impact factor: 6.823

View more
  10 in total

Review 1.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

2.  ICAM-1: isoforms and phenotypes.

Authors:  Theresa N Ramos; Daniel C Bullard; Scott R Barnum
Journal:  J Immunol       Date:  2014-05-15       Impact factor: 5.422

3.  Carbohydrates: Binding Sites and Potential Drug Targets for Neural-Affecting Pathogens.

Authors:  Cara-Lynne Schengrund
Journal:  Adv Neurobiol       Date:  2023

Review 4.  Cerebral Malaria: Current Clinical and Immunological Aspects.

Authors:  Karin Albrecht-Schgoer; Peter Lackner; Erich Schmutzhard; Gottfried Baier
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

5.  Maladjusted host immune responses induce experimental cerebral malaria-like pathology in a murine Borrelia and Plasmodium co-infection model.

Authors:  Johan Normark; Maria Nelson; Patrik Engström; Marie Andersson; Rafael Björk; Thomas Moritz; Anna Fahlgren; Sven Bergström
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

6.  Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.

Authors:  Adéla Nacer; Alexandru Movila; Fabien Sohet; Natasha M Girgis; Uma Mahesh Gundra; P'ng Loke; Richard Daneman; Ute Frevert
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

7.  Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators.

Authors:  Kim E Schmidt; Janina M Kuepper; Beatrix Schumak; Judith Alferink; Andrea Hofmann; Shanshan W Howland; Laurent Rénia; Andreas Limmer; Sabine Specht; Achim Hoerauf
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

Review 8.  Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.

Authors:  D Channe Gowda; Xianzhu Wu
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

Review 9.  Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment.

Authors:  Xiaonan Song; Wei Wei; Weijia Cheng; Huiyin Zhu; Wei Wang; Haifeng Dong; Jian Li
Journal:  Front Cell Infect Microbiol       Date:  2022-07-25       Impact factor: 6.073

Review 10.  Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain.

Authors:  Mariana C Souza; Tatiana A Padua; Maria G Henriques
Journal:  Mediators Inflamm       Date:  2015-09-30       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.